These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 25632141)

  • 21. Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.
    Flores-Aguilar L; Iulita MF; Kovecses O; Torres MD; Levi SM; Zhang Y; Askenazi M; Wisniewski T; Busciglio J; Cuello AC
    Brain; 2020 Dec; 143(12):3653-3671. PubMed ID: 33206953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration.
    Galán-Ganga M; Rodríguez-Cueto C; Merchán-Rubira J; Hernández F; Ávila J; Posada-Ayala M; Lanciego JL; Luengo E; Lopez MG; Rábano A; Fernández-Ruiz J; Lastres-Becker I
    Acta Neuropathol Commun; 2021 May; 9(1):90. PubMed ID: 34001284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
    Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
    Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular functions of the dual-targeted catalytic subunit of telomerase, telomerase reverse transcriptase--potential role in senescence and aging.
    Ale-Agha N; Dyballa-Rukes N; Jakob S; Altschmied J; Haendeler J
    Exp Gerontol; 2014 Aug; 56():189-93. PubMed ID: 24583100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hippocampal microvasculature changes in association with oxidative stress in Alzheimer's disease.
    Sen A; Hongpaisan J
    Free Radic Biol Med; 2018 May; 120():192-203. PubMed ID: 29572097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
    Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM
    Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase activity-independent function of telomerase reverse transcriptase is involved in acrylamide-induced neuron damage.
    Zhang P; Pan H; Wang J; Liu X; Hu X
    Biotech Histochem; 2014 Jul; 89(5):327-35. PubMed ID: 24279610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.
    Yarchoan M; Toledo JB; Lee EB; Arvanitakis Z; Kazi H; Han LY; Louneva N; Lee VM; Kim SF; Trojanowski JQ; Arnold SE
    Acta Neuropathol; 2014 Nov; 128(5):679-89. PubMed ID: 25107476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
    Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo.
    Bolós M; Llorens-Martín M; Jurado-Arjona J; Hernández F; Rábano A; Avila J
    J Alzheimers Dis; 2016; 50(1):77-87. PubMed ID: 26638867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
    Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
    Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.
    Maphis N; Xu G; Kokiko-Cochran ON; Jiang S; Cardona A; Ransohoff RM; Lamb BT; Bhaskar K
    Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral Delivery of Non-Mutated Human Truncated Tau to Neurons Recapitulates Key Features of Human Tauopathy in Wild-Type Mice.
    Vogels T; Vargová G; Brezováková V; Quint WH; Hromádka T
    J Alzheimers Dis; 2020; 77(2):551-568. PubMed ID: 32675411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function.
    Fu W; Killen M; Culmsee C; Dhar S; Pandita TK; Mattson MP
    J Mol Neurosci; 2000; 14(1-2):3-15. PubMed ID: 10854032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
    Vingtdeux V; Davies P; Dickson DW; Marambaud P
    Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.